Rare lymphomas in routine practice—Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms

Waldenström's macroglobulinaemia (WM) is a rare indolent B‐cell lymphoma for which only little prospective phase III evidence exists. Thus, real world data are important to provide insight into treatment and survival. We present here data on choice and outcome of systemic treatment of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Knauf, Wolfgang, Abenhardt, Wolfgang, Slawik, Hans Rainer, Bückner, Ute, Otremba, Burkhard, Sauer, Annette, Zahn, Mark‐Oliver, Wetzel, Natalie, Kaiser‐Osterhues, Anja, Houet, Leonora, Marschner, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497085/
https://www.ncbi.nlm.nih.gov/pubmed/32383192
http://dx.doi.org/10.1002/hon.2740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497085/
https://www.ncbi.nlm.nih.gov/pubmed/32383192
http://dx.doi.org/10.1002/hon.2740

Ejemplares similares